XNCR
Xencor, Inc.$14.85-0.08 (-0.54%)Prev Close$14.95·MCap$1.11B·P/E—·Vol250.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
12
$3.77M
◆
Net Activity
Net Seller
$3.77M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Xencor, Inc. (XNCR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 12 insider sales totaling $3.77M. The most recent insider transaction was by Feigal Ellen (director), who sold $89.4K worth of shares on Jun 22, 2026. Xencor, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.11B.
XNCR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Feigal Ellen | director | Sell | 6,843 | $13.06 | $89.4K | 12,340-36% |
| Jun 17, 2026 | Montgomery Alan Bruce | director | Sell | 5,064 | $12.31 | $62.3K | 15,547 |
| Jun 17, 2026 | RANIERI RICHARD J | director | Sell | 5,474 | $12.31 | $67.4K | 13,709-29% |
| Jun 17, 2026 | GUSTAFSON KURT A | director | Sell | 5,474 | $12.31 | $67.4K | 14,709-27% |
| Jun 17, 2026 | GORMAN KEVIN CHARLES | director | Sell | 7,527 | $12.31 | $92.7K | 11,378-40% |
| Apr 13, 2026 | Cornelissen Bart Jan | officer: SR. VICE PRESIDENT & CFO | Sell | 3,499 | $12.29 | $43.0K | 75,898 |
| Mar 9, 2026 | Cornelissen Bart Jan | officer: SR. VICE PRESIDENT & CFO | Sell | 2,517 | $11.25 | $28.3K | 79,397 |
| Mar 9, 2026 | Dahiyat Bassil I | director, officer: PRESIDENT & CEO | Sell | 21,476 | $11.18 | $240.0K | 552,922 |
| Mar 9, 2026 | Desjarlais John R | officer: SR. VICE PRESIDENT & CSO | Sell | 6,620 | $11.16 | $73.9K | 266,333 |
| Mar 9, 2026 | Eckert Celia | officer: SVP, GENERAL COUNSEL | Sell | 5,011 | $11.17 | $56.0K | 78,685 |
| Dec 19, 2025 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 114,377 | $15.71 | $1.80M | 0 |
| Dec 19, 2025 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 73,367 | $15.72 | $1.15M | 0 |
| Jun 12, 2025 | GORMAN KEVIN CHARLES | Director | Sell | 3,173 | $9.22 | $29.3K | 0 |
| Jun 12, 2025 | GUSTAFSON KURT A | Director | Sell | 2,993 | $9.22 | $27.6K | 0 |
| Jun 12, 2025 | Montgomery Alan Bruce | Director | Sell | 2,215 | $9.22 | $20.4K | 0 |
| May 2, 2025 | Valente Nancy | EVP, Chief Development Officer | Sell | 4,616 | $11.03 | $50.9K | 0 |
| Apr 10, 2025 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Sell | 3,750 | $8.06 | $30.2K | 0 |
| Mar 10, 2025 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 19,716 | $13.60 | $268.1K | 0 |
| Mar 10, 2025 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 9,697 | $13.60 | $131.9K | 0 |
| Mar 10, 2025 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 5,740 | $13.60 | $78.0K | 0 |
| Mar 10, 2025 | Valente Nancy | EVP, Chief Development Officer | Sell | 2,565 | $13.60 | $34.9K | 0 |
| Dec 4, 2024 | Montgomery Alan Bruce | Director | Sell | 14,722 | $27.03 | $397.9K | 9,140-62% |
| Nov 25, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 49,278 | $24.07 | $1.19M | 352,615 |
| Nov 14, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 3,366 | $24.02 | $80.8K | 352,615 |
| Nov 13, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 68,684 | $23.48 | $1.61M | 200,104-26% |
| Oct 1, 2024 | GORMAN KEVIN CHARLES | Director | Sell | 2,654 | $20.68 | $54.9K | 8,392 |
| Oct 1, 2024 | GUSTAFSON KURT A | Director | Sell | 2,503 | $20.68 | $51.8K | 9,490 |
| Oct 1, 2024 | Montgomery Alan Bruce | Director | Sell | 1,853 | $20.68 | $38.3K | 9,140 |
| Oct 1, 2024 | ROSA-BJORKESON DAGMAR | Director | Sell | 2,503 | $20.68 | $51.8K | 8,490 |
| Jul 11, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 36,329 | $18.32 | $665.5K | 192,319 |
| May 3, 2024 | Valente Nancy | EVP, Chief Development Officer | Sell | 4,745 | $23.58 | $111.9K | 55,115 |
| Mar 12, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 2,741 | $23.50 | $64.4K | 351,894 |
| Mar 12, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 1,280 | $23.50 | $30.1K | 186,433 |
| Mar 12, 2024 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 850 | $23.50 | $20.0K | 45,465 |
| Mar 12, 2024 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 849 | $23.50 | $20.0K | 121,070 |
| Mar 7, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 12,528 | $23.43 | $293.5K | 300,097 |
| Mar 7, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 6,629 | $23.43 | $155.3K | 166,989 |
| Mar 7, 2024 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 3,892 | $23.43 | $91.2K | 33,226 |
| Mar 7, 2024 | GUSTAFSON KURT A | Director | Sell | 14,000 | $23.18 | $324.5K | 6,007-70% |
| Mar 7, 2024 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 4,474 | $23.43 | $104.8K | 121,919 |
| Feb 15, 2024 | GORMAN KEVIN CHARLES | Director | Buy | 53 | $19.12 | $1.0K | 5,060 |
| Feb 14, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 54,108 | $19.38 | $1.05M | 161,675-25% |
| Dec 29, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 45,000 | $20.93 | $941.7K | 312,929 |
| Jun 22, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 33,497 | $26.19 | $877.3K | 292,216 |
| Mar 13, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 2,602 | $29.88 | $77.7K | 249,701 |
| Mar 13, 2023 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 1,230 | $29.88 | $36.8K | 147,726 |
| Mar 13, 2023 | Eckert Celia | VP, GENERAL COUNSEL | Sell | 711 | $29.88 | $21.2K | 36,976 |
| Mar 13, 2023 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 711 | $29.88 | $21.2K | 126,230 |
| Mar 13, 2023 | Yang Allen | SR. VICE PRESIDENT & CMO | Sell | 1,094 | $29.88 | $32.7K | 73,364 |
| Mar 8, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 5,831 | $31.42 | $183.2K | 252,303 |
Showing 1–50 of 73
1 / 2
XNCR Insider Buying Activity
The following table shows recent insider purchases of Xencor, Inc. (XNCR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | GORMAN KEVIN CHARLES | Director | Buy | 53 | $19.12 | $1.0K | 5,060 |
XNCR Insider Selling Activity
The following table shows recent insider sales of Xencor, Inc. (XNCR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Feigal Ellen | director | Sell | 6,843 | $13.06 | $89.4K | 12,340-36% |
| Jun 17, 2026 | Montgomery Alan Bruce | director | Sell | 5,064 | $12.31 | $62.3K | 15,547 |
| Jun 17, 2026 | RANIERI RICHARD J | director | Sell | 5,474 | $12.31 | $67.4K | 13,709-29% |
| Jun 17, 2026 | GUSTAFSON KURT A | director | Sell | 5,474 | $12.31 | $67.4K | 14,709-27% |
| Jun 17, 2026 | GORMAN KEVIN CHARLES | director | Sell | 7,527 | $12.31 | $92.7K | 11,378-40% |
| Apr 13, 2026 | Cornelissen Bart Jan | officer: SR. VICE PRESIDENT & CFO | Sell | 3,499 | $12.29 | $43.0K | 75,898 |
| Mar 9, 2026 | Cornelissen Bart Jan | officer: SR. VICE PRESIDENT & CFO | Sell | 2,517 | $11.25 | $28.3K | 79,397 |
| Mar 9, 2026 | Dahiyat Bassil I | director, officer: PRESIDENT & CEO | Sell | 21,476 | $11.18 | $240.0K | 552,922 |
| Mar 9, 2026 | Desjarlais John R | officer: SR. VICE PRESIDENT & CSO | Sell | 6,620 | $11.16 | $73.9K | 266,333 |
| Mar 9, 2026 | Eckert Celia | officer: SVP, GENERAL COUNSEL | Sell | 5,011 | $11.17 | $56.0K | 78,685 |
| Dec 19, 2025 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 114,377 | $15.71 | $1.80M | 0 |
| Dec 19, 2025 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 73,367 | $15.72 | $1.15M | 0 |
| Jun 12, 2025 | GORMAN KEVIN CHARLES | Director | Sell | 3,173 | $9.22 | $29.3K | 0 |
| Jun 12, 2025 | GUSTAFSON KURT A | Director | Sell | 2,993 | $9.22 | $27.6K | 0 |
| Jun 12, 2025 | Montgomery Alan Bruce | Director | Sell | 2,215 | $9.22 | $20.4K | 0 |
| May 2, 2025 | Valente Nancy | EVP, Chief Development Officer | Sell | 4,616 | $11.03 | $50.9K | 0 |
| Apr 10, 2025 | Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | Sell | 3,750 | $8.06 | $30.2K | 0 |
| Mar 10, 2025 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 19,716 | $13.60 | $268.1K | 0 |
| Mar 10, 2025 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 9,697 | $13.60 | $131.9K | 0 |
| Mar 10, 2025 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 5,740 | $13.60 | $78.0K | 0 |
| Mar 10, 2025 | Valente Nancy | EVP, Chief Development Officer | Sell | 2,565 | $13.60 | $34.9K | 0 |
| Dec 4, 2024 | Montgomery Alan Bruce | Director | Sell | 14,722 | $27.03 | $397.9K | 9,140-62% |
| Nov 25, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 49,278 | $24.07 | $1.19M | 352,615 |
| Nov 14, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 3,366 | $24.02 | $80.8K | 352,615 |
| Nov 13, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 68,684 | $23.48 | $1.61M | 200,104-26% |
| Oct 1, 2024 | GORMAN KEVIN CHARLES | Director | Sell | 2,654 | $20.68 | $54.9K | 8,392 |
| Oct 1, 2024 | GUSTAFSON KURT A | Director | Sell | 2,503 | $20.68 | $51.8K | 9,490 |
| Oct 1, 2024 | Montgomery Alan Bruce | Director | Sell | 1,853 | $20.68 | $38.3K | 9,140 |
| Oct 1, 2024 | ROSA-BJORKESON DAGMAR | Director | Sell | 2,503 | $20.68 | $51.8K | 8,490 |
| Jul 11, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 36,329 | $18.32 | $665.5K | 192,319 |
| May 3, 2024 | Valente Nancy | EVP, Chief Development Officer | Sell | 4,745 | $23.58 | $111.9K | 55,115 |
| Mar 12, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 2,741 | $23.50 | $64.4K | 351,894 |
| Mar 12, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 1,280 | $23.50 | $30.1K | 186,433 |
| Mar 12, 2024 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 850 | $23.50 | $20.0K | 45,465 |
| Mar 12, 2024 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 849 | $23.50 | $20.0K | 121,070 |
| Mar 7, 2024 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 12,528 | $23.43 | $293.5K | 300,097 |
| Mar 7, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 6,629 | $23.43 | $155.3K | 166,989 |
| Mar 7, 2024 | Eckert Celia | SVP, GENERAL COUNSEL | Sell | 3,892 | $23.43 | $91.2K | 33,226 |
| Mar 7, 2024 | GUSTAFSON KURT A | Director | Sell | 14,000 | $23.18 | $324.5K | 6,007-70% |
| Mar 7, 2024 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 4,474 | $23.43 | $104.8K | 121,919 |
| Feb 14, 2024 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 54,108 | $19.38 | $1.05M | 161,675-25% |
| Dec 29, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 45,000 | $20.93 | $941.7K | 312,929 |
| Jun 22, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 33,497 | $26.19 | $877.3K | 292,216 |
| Mar 13, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 2,602 | $29.88 | $77.7K | 249,701 |
| Mar 13, 2023 | Desjarlais John R | SR. VICE PRESIDENT & CSO | Sell | 1,230 | $29.88 | $36.8K | 147,726 |
| Mar 13, 2023 | Eckert Celia | VP, GENERAL COUNSEL | Sell | 711 | $29.88 | $21.2K | 36,976 |
| Mar 13, 2023 | Kuch John J | SR. VICE PRESIDENT & CFO | Sell | 711 | $29.88 | $21.2K | 126,230 |
| Mar 13, 2023 | Yang Allen | SR. VICE PRESIDENT & CMO | Sell | 1,094 | $29.88 | $32.7K | 73,364 |
| Mar 8, 2023 | Dahiyat Bassil I | PRESIDENT & CEO | Sell | 5,831 | $31.42 | $183.2K | 252,303 |
XNCR Insiders
Similar Stocks to XNCR
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B